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’INTRODUCTION
Prediction of substrate selectivity of human cytochrome P450
(CYP)enzymesisachallengingtask.Theseenzymesarerespon-
sible for the oxidation of many diﬀerent substrates (including
drugs), often resulting in the formation of a variety of products,
some of which are toxic.
1 Two major factors that inﬂuence
selectivity are the steric and electrostatic interactions between
theproteinandsubstratewhichcontrolthesubstrateorientation,
and the intrinsic reactivity of the substrate with respect to the
active oxygenating species, Compound I (Cpd I).
2 The latter
factor has been postulated to be dependent on the electronic
structure of Cpd I.
3,4 Better understanding of the factors that
inﬂuence Cpd I reactivity could contribute signiﬁcantly to drug
development
5andtootherpracticalapplications,suchasuseand
engineering of CYPs for biocatalysis.
6
The electronic structure of Cpd I has been shown previously
to be sensitive to the electrostatic and hydrogen-bonding inter-
actions within the protein as well as the identity of the axial
ligand, which in the case of CYPs is a cysteinate.
711 Such
diﬀerences in the electronic structure of Cpd I include the
amount of unpaired electron density located on the cysteinate
sulfur, as is discussed below. Analogous diﬀerences have been
observedbetweenperoxidaseenzymes,e.g.,thediﬀerentlocation
of an unpaired electron observed in the electronic structures of
Cpd I in cyctochrome c peroxidase and ascorbate peroxidase.
12
Observed diﬀerences in the electronic structure of CYP Cpd I
have largely been based on quantum mechanical (QM) calcula-
tions, mostly using density functional theory (DFT), for a small
modeloftheenzymeactivesite.Itisalsocommonlybelievedthat
theelectronicstructureof CpdI canbetunedbytheenzyme,thus
aﬀecting the regioselectivity of oxidation for some substrates.
4,13
Thepresenceofsubstratehasbeenpreviouslyproposedtoincrease
thestabilityofCpdIinCYP3A4.
14AsdiﬀerentCYPisoformsvary
in overall size, size of active site, and sequence of amino acid
residues, it is conceivable that the electronic structure of Cpd I
might vary between diﬀerent isoforms. Previous work gives con-
ﬂicting views on the signiﬁcance of this eﬀect,
14,15 as is described
below. Here the extent to which the electronic structure of Cpd I
varies between isoforms is probed more rigorously.
Cpd I is a transient species and has only been isolated
experimentally for the CYP119 isoform,
16 although it has been
isolatedinotherenzymes,suchascytochromecperoxidase
17and
horseradish peroxidase.
18 It is therefore presently not possible to
comparetheelectronic structureof diﬀerentCYPisoforms using
experimentaltechniques.IftheelectronicstructureofCpdIdoes
vary between isoforms, then it could be partially responsible for
the diﬀerent products formed in diﬀerent isoforms. The pro-
posed ability of the enzyme environment to tune the electronic
structure of Cpd I has been termed “chameleon” behavior.
3,10
The implications of this proposed behavior would be signiﬁcant
and may compromise models that aim to predict CYP reactivity
based on Cpd I having identical behavior in all isoforms, e.g.,
MetaSite.
19 As multiple CYP isoforms in the human body are
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responsible for the metabolism of drugs, any possible diﬀerence
inCpdIreactivitybetweenisoformsshouldbeexplored.Itisalso
possiblethatthevariationsintheenzymeenvironmentsurround-
ingthecysteinatearenotsigniﬁcantenoughtocauseanetchange
in the electronic structure of Cpd I and that observed changes in
calculations on large models of P450 are due to thermal ﬂuctua-
tionsintheenzymeenvironment.Themainaimofthisstudyisto
test thoroughly which of these two interpretations is correct.
Electronic Structure of Cpd I. Cpd I is a triradicaloid species
with three singly occupied molecular orbitals. These orbitals
(shown in Figure 1) consist of two π* antibonding FeO
orbitals and a third that is a combination of a porphyrin π orbital
with idealizeda2u symmetry and ap orbital on sulfur.Depending
on the relative orientation of the spins of the two unpaired
electrons on the FeO moiety and the third unpaired electron,
one obtains a quartet or doublet spin state (denoted
4A2u and
2A2u), which are found to be near-degenerate in electronic
structure calculations.
15,20 In QM (DFT) calculations on small
models, the distribution of the spin density in the a2u orbital
varies,dependingonthetreatmentofthecysteinateligandandits
environment. The inclusion of NHS hydrogen bonds in these
models increases the amount of spin density distributed over the
porphyrin ring by effectively lowering the energy of the sulfur
lone pair orbital.
3 These NHS hydrogen bonds mimic the
hydrogen bonds that are formed between the cysteinate sulfur
and three neighboring amino acids (see Figure 2 and Table 1).
Theintroductionofapolarizingelectricfieldhasasimilareffect.
4
DFT calculations using a mercaptide (
SCH3) or cysteinate
anion, without the inclusion of the above-mentioned hydrogen-
bonding interactions, lead to the prediction of two further low-
energy states, in which the third unpaired electron is located
almost exclusively within a different p orbital on the sulfur atom,
giving rise to
4,2ΠS states.
8,2123 These
4,2ΠS states are incon-
sistent with experimental studies of Cpd I in chloroperoxidase
24
and CYP119,
16 which are green in color and more consistent
with
2,4A2u states. In the recent spectroscopic characterization of
Cpd I in CYP119,
16 the UVvis and M€ ossbauer spectra were
discovered to be similar to those of chloroperoxidase, and the
CpdIspeciesinCYPsisthereforeexpectedtohave
2,4A2uground
states.
The FeS bond length also is sensitive to the environment
and treatment of the cysteinate ligand. It shortens by 0.1 Å when
hydrogen bonding and a polarizing electric ﬁeld in the direction
of the FeS bond are included in QM (DFT) calculations on
smallmodels.
3,4,10,20Itwastheseobservationsthatﬁrstledtothe
description of Cpd I as a chameleon species that changes its
electronic structure according to its environment.
4
The electronic structure of Cpd I in CYPs 2C9, 3A4, 2B4, and
P450cam has been previously investigated using density func-
tional quantum mechanics/molecular mechanics (QM/MM)
methods by Bathelt et al.
15,29 The sulfur spin density and FeS
bond length were used in that work as a means of comparing the
electronic structure ofCpdIintheisoforms studied. Byenabling
the treatment of much larger models, QM/MM calculations are
able to describe the hydrogen bonding and electrostatic environ-
ment of the thiolate group better than typical small-model QM
studies, and this is generally found to lead to shorter FeS
optimizedbondlengthsandlowerunpairedelectronspindensity
on sulfur.
9,15 The FeS bond lengths and sulfur spin densities
in the QM/MM calculations were found to be insensitive to in-
creasing the size of the QM region, to include either the
porphyrin substituents or the full coordinating cysteinate.
15
The electronic structure of Cpd I was found to vary slightly
Figure 2. Residues surrounding the cysteinate sulfur in the crystal
structuresofP450cam(1DZ9,green),CYP2C9(1OG5,black),CYP2D6
(2F9Q, blue), and CYP3A4 (1TQN, red).
Table 1. Residues in P450cam, CYP2C9, CYP2D6, and
CYP3A4 (Resn+1, Resn+2, and Resn+3) Involved in the
Hydrogen-Bond Network Surrounding the Fe-Bound
Cysteinate (Resn)
a
isoform PDB code Resn Resn+1 Resn+2 Resn+3
P450cam 1DZ9 Cys357 Leu358 Gly359 Gln360
CYP2C9 1OG5 Cys435 Val436 Gly437 Glu438
CYP2D6 2F9Q Cys443 Leu444 Gly445 Glu446
CYP3A4 1TQN Cys442 Ile443 Gly444 Met445
aThe numbering of the residues corresponds to the crystal structures
1DZ9,
25 1OG5,
26 2F9Q,
27 and 1TQN.
28
Figure1. FrontierorbitalsofCpdI:(a)istheporphyrina2uorbitalwithsigniﬁcantcontributionfromthesulfurporbital;and(b)and(c)arethetwoπ*
antibonding FeO orbitals. Calculated in vacuo at the B3LYP/LACVP level.15466 dx.doi.org/10.1021/ja203157u |J. Am. Chem. Soc. 2011, 133, 15464–15474
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between the isoforms. The largest diﬀerence was observed
between the human CYPs and the bacterial P450cam. However,
two calculations on the same isoform, starting from diﬀerent
initial structures (generated from molecular dynamics (MD)
trajectories) exhibited similar diﬀerences in FeS bond length
and sulfur spin density to those found between two calculations
on diﬀerent isoforms. A small change was also observed when
comparing an isoform in the presence and absence of a sub-
strate molecule in its active site cavity. It was suggested from
those QM/MM calculations that the diﬀerences in electronic
structure and FeS bond length were due tothermal motions of
the protein, substrate, and solvent. These motions cause the
hydrogen-bonding environment and electric ﬁeld surrounding
Cpd I to vary, but the preliminary conclusion of this early study
wasthattherewasnonetdiﬀerencebetweenisoforms,giventhat
thethermallyinducedﬂuctuationswereaslargeorlargerthanthe
changes obtained from one isoform to another.
The eﬀect of the presence of substrate in the active site of
CYPs on the electronic structure of Cpd I has been investigated
byothers.Thedrug-metabolizinghumanCYPisoform,CYP3A4,
has been associated with multiple substrate binding and possible
allosteric mechanisms.
3033 Fishelovitch et al. performed QM/
MMcalculationsontheelectronicstructureofCpdIofCYP3A4
using various models in which the enzyme was either substrate-
free or contained one or two substrate molecules.
14 They found
that in the absence of substrate, the FeS bond tended to
elongate thus localizing the unpaired electron on the sulfur. In
themodelwherethesubstratediazepamislocatedclosetoCpdI,
the NHS interactions with the cysteinate ligand were found to
be strengthened, with a resultant shortening of the FeS bond
and delocalization of the unpaired electron over the porphyrin
ring and cysteinate sulfur. However, the conclusion that the
absence of substrate leads to an increase in FeS bond length
was based on geometry optimization of relatively few snapshots
obtained from a 500 ps MD simulation. Due to the many
accessible energy minima in proteins, extensive conformational
sampling must be performed, in order to reliably calculate
structural, electronic, and energetic properties.
34,35 In the work
presented here, many more snapshots have been optimized with
QM/MM, from longer MD simulations, to increase the amount
of conformational sampling.
Wealsointroducehere anapproximatemethod forestimating
the FeO bond enthalpy in Cpd I, which can be linked directly
tothestabilityandoxidizingpowerofCpdI.Previousworkbyde
Visser showed that the calculated barriers to hydrogen abstrac-
tion by both heme and nonheme iron(IV)-oxo oxidants
(including CYP) correlate with the energy of the Fe(III)OH
bond, which is formed after the abstraction step.
36 The energyof
the Fe(III)OH bond was shown to be sensitive to the metal
ligands that are both cis and trans to the OH ligand. It would
not be straightforward to calculate the OH bond energy
associated with adding a hydrogen atom to Cpd I in a QM/
MM framework. As hydrogen atom addition leads to an increase
in the FeO bond length and a decrease in the formal FeO
bond order, FeO and OH bond strengths for Cpd I in
diﬀerentenvironmentsshouldbeanticorrelated,andwefocuson
calculating the former. Further correlations have been observed,
both experimentally
37 and computationally,
36,38,39 between the
barrier to substrate hydroxylation and the CH bond energy
involved inthe hydrogen abstraction step. Recently, Kumar et al.
reported a correlation between the rate constant of substrate
epoxidation and the ionization potential of the substrate for Cpd
I in CYPs and analogous Fe(IV)dO species.
39 Correlations
between calculations and experimentally observed properties
(such as rate constants) can provide a powerful tool for aiding
the understanding of the reactivity in these and other enzymes
40
and could, for example, aid the design of biomimetic catalysts.
The electronic structure and FeO bond enthalpy is calcu-
lated for several diﬀerent CYP isoforms and compared here. We
focus on four important and well-studied isoforms: the human
2C9, 2D6, and 3A4 isoforms are the major isoforms responsible
for the metabolism of 75% of drugs.
41,42 The bacterial P450cam
isoform from Pseudomonas putida was the ﬁrst CYP to be
crystallized (and hence is the most studied) and is also
studied here.
’COMPUTATIONAL DETAILS
X-ray Crystal Structures. The human isoforms CYP2C9,
CYP2D6, and CYP3A4 were modeled in this work, along with the
bacterial P450cam isoform. Two crystal structures, both obtained by
Williams et al.,
43 were used for the calculations on CYP2C9; the 1OG2
structure was used for simulating CYP2C9 in the absence of substrate,
while the 1OG5 structure was used for all simulations containing the
substrate S-warfarin. Theonly currentlyavailable crystalstructure (PDB
code 2F9Q)
44 solved by Rowland et al. was used for studying CYP2D6.
Several crystal structures of CYP3A4 are available, of which we used the
structure (PDB code 1TQN) obtained by Yano et al.
45 The 1DZ9
structure, solved by Schlichting et al., was used as the starting structure
forallcalculationsonP450cam.
25Ineachcase,wheremutationshadbeen
introduced to facilitate crystallization, these mutations were reversed in
silico with the SwissPDB program,
46 prior to MD and QM/MM
calculations, to restore the wild-type enzyme.
MD Simulations. Stochastic boundary MD (and MM energy
minimizations) were carried out using the CHARMM program, version
30b2
47 and the CHARMM27 MM force field.
48 Further details con-
cerning program-specific options and parameters for nonstandard
residues are contained in the Supporting Information.
Four simulations were carried out on CYP2C9. The simulation
originating from the 1OG2 crystal structure in the absence of substrate
will be referred to as 2C9_apo. Three separate simulations were carried
out that originated from the 1OG5 crystal structure. The ﬁrst of these,
referred to as 2C9_dist, was derived from the original crystal structure,
containing S-warfarin (Figure 2) in the distal cavity. The second
simulation, referred to as 2C9_2warf, used the 1OG5 structure with a
second molecule ofS-warfarin docked intothe active site, directlyabove
CpdI,inapositionfavoringoxidationattheC7position.Hydroxylation
atthiscarbonatomisthepredominantoxidationpathwayinmetabolism
by this isoform.
49 This second substrate molecule was docked into the
active site cavity using the AUTODOCK program.
50 The third simula-
tion originating from the 1OG5 crystal structure is referred to as
2C9_prox and refers to the 2C9_2warf structure with the distal
molecule of S-warfarin removed, leaving the proximal molecule
remaining.
CalculationsontwofurtherhumanCYPisoforms,3A4and2D6,were
also carried out. These were both studied in substrate-free states
(3A4_apo and 2D6_apo) and also in complexes with a single molecule
of dextromethorphan (Figure 2), bound in a proximal position relative
to CpdI(3A4_dexand2D6_dex).
51Metabolismofdextromethorphan
by CYP2D6 occurs by demethylation of the oxygen atom, whereas in
CYP3A4 metabolism occurs by demethylation at the nitrogen atom.
52
TwosimulationswereperformedonP450cam,usingthe1DZ9crystal
structure. The natural substrate camphor was removed in both simula-
tions. In one simulation, propene was docked (by hand) into the
active site cavity (P450cam_prop). The other simulation was run in15467 dx.doi.org/10.1021/ja203157u |J. Am. Chem. Soc. 2011, 133, 15464–15474
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the absence of a substrate molecule docked into the active site
(P450cam_apo). We have studied propene oxidation by P450cam
previously,
35,53 using MM MD and QM/MM methods, and observed
that propene displays extensive mobility in the active site due to it is
small size and absence of hydrogen-bonding groups.
Each simulation had a production phase of 5 ns and snapshots were
taken at 200 ps intervals. Each snapshot was ﬁrst minimized in
CHARMM
47 using the same (CHARMM27) MM force ﬁeld as in the
MD simulations, with 500 steps of the steepest descent algorithm
followed by 1500 steps of adapted basis NewtonRaphson minimiza-
tion, prior to QM/MM minimization.
The crystal structure of CYP2D6 that was used
27 does not contain
anyactivesitewatermoleculesdirectlyabovetheheme.Inthe2D6_apo
model, it was foundthat only one water molecule had beenadded in the
regionabovetheCpdIoxygenduringthesolvationprotocol.Thiswater
molecule formed a hydrogen bond with the Cpd I ferryl oxygen at the
startoftheheatingphasebutlefttheactivesitepriortotheequilibration
phase. For the equilibration phase and ﬁrst 3 ns of the production phase
dynamics, the active site region above the Cpd I oxygen did not contain
any water. After the 3 ns point, several water molecules ﬂowed into the
active site from the entrance channel, and the active site remained
solvated for the rest of the simulation. For this reason, only the last 2 ns
of these simulations were considered for the data presented here.
QM/MM Calculations. The structure of each MM-minimized
snapshot described above was energy minimized using QM/MM. The
QM region included the porphyrin ring without substituents and the
cysteinate ligand, modeled as a methyl mercaptide,
SCH3. In calcula-
tions on models containing substrate, part or all of one substrate
molecule, as described below, was included in the QM region, with
theexceptionofthe3A4_dexcalculations,wherethedextromethorphan
wastreatedpurelyattheMMlevel.Asdiscussedbelow,thetreatmentof
thesubstrate(i.e.,whetheritwasincludedintheQMorMMregion)was
found to have no effect on the computed electronic structure of Cpd I.
For the P450cam_prop system, the entire propene molecule was
included in the QM region. For calculations including S-warfarin, the
S-warfarin molecule was split into QM and MM regions, as shown in
Figure 3. Similarly, in the case of the 2D6_dex calculations, the
dextromethorphan molecule was split into QM and MM regions, as
shown in Figure 3. The valences of the QM atoms at the QM/MM
boundary were satisfied by the addition of link atoms, which
were modeled as hydrogen atoms.
54 In the 2C9_2warf calculations,
the proximal molecule of S-warfarin was split into two parts, one in the
QM region and one in the MM region, while the distal substrate
molecule was in the MM region.
Inthe2D6_dexmodel,theN-protonatedformofdextromethorphan
was used (as shown in Figure 3),
51 because almost all substrates of
CYP2D6includeabasicnitrogenwhichisthoughttointeractwithone
of the acidic residues (Asp301 or Glu216) of the active site.
44 In
contrast, CYP3A4 is known to metabolize a wide range of substrates,
many with large hydrophobic groups, and it is likely that dextro-
methorphan binds in a nonionized form to its active site.
55 Therefore
in the 3A4_dex simulations, the unprotonated form of dextromethor-
phan was used.
The QM part of the QM/MM calculations was performed in Jaguar
5.5
56 using the B3LYP density functional.
5760 The LACVP basis set
(and associated core potential) was used for iron and the 6-31G* basis
set forall other atoms.
61 This combination of basis sets has beenused in
previouscalculationsandshowntoagreewellwithcalculationsusingthe
largerbasissetLACV3Pforironand6-311G*forallotheratoms.
15Since
the quartet and doublet spin states lie within 1.0 kcal mol
1 of each
other, only the quartet state was modeled in these calculations, using a
restricted open-shell approach. The MM region was optimized at every
QM step with the Tinker program
62 using the CHARMM27 force
ﬁeld.
48 Theﬁxed charges from the MMregion were included in the QM
Hamiltonian, allowing for the QM region to be polarized by the rest of
the protein. No nonbonded cutoﬀ was employed in any QM/MM
calculation here. The QM and MM calculations were linked using the
QoMMMainterface.
51,63Thesamelinkatomapproachdescribedabove
for S-warfarin and dextromethorphan was used to satisfy the valence of
the atoms atthe QM/MM boundary on the hemeand the cysteine. The
MM charges on the link atoms, along with neighboring atoms, were set
to zero to avoid any unphysical eﬀects.
35 The charges on these atoms
were shifted onto adjacent groups where necessary in order to maintain
the same overall charge for each system.
15,35,6365 The QM/MM
methodology used here has been shown previously to model reliably
the hydrogen-bonding interactions between the QM and MM
subsystems.
66
Estimation of the FeO Bond Enthalpy in Cpd I. The QM/
MM optimized snapshots mentioned above were used to estimate the
bond enthalpy of the iron atom and ferryl oxygen of Cpd I. The main
purpose of this was to assess whether a variation in this bond enthalpy
exists between different CYP isoforms. This would indicate possible
differences in the oxidizing power of Cpd I between different isoforms.
Accuratecalculationofbondenthalpiesinsystemswithlargenumbersof
atoms is not straightforward, due to the need to sample many different
structures of the bonded system and the fragments.
34,67 The approach
used here is approximate but importantly includes significant averaging.
The importance of the FeO bond energy for reactivity is illustrated
in the thermodynamic cycle in Figure 4. ΔE1 corresponds to the energy
of oxidation of the substrate by Cpd I to form the product and resting
state of the heme. The value of ΔE1 is dependent on the substrate,
because it involves conversion of the substrate into product as well as
breakage oftheFeObondofCpdI.ΔE1mustbenegative(orpositive
but small in magnitude) for oxidation to occur, and oxidation can be
expectedtobemorefacilethemorenegativeΔE1is.Thisquantitycanbe
expressed as ΔE1 = ΔE2 + ΔE3, where ΔE2 is the energy required to
break the FeO bond in Cpd I, and ΔE3 is the energy released upon
addition of the oxygen atom to the substrate to yield product. ΔE2 is to a
ﬁrstapproximationindependentofthesubstrate,andsmallervaluesofthis
bond energy correspond to a more reactive and oxidizing state of Cpd I.
To estimate ΔE2 in a given enzyme environment, we started from
each Cpd I structure optimized at the QM/MM level and its energy
EQM/MM(FeO). Then, the QM/MM energy of this structure was
recomputed after simply deleting the ferryl oxygen atom, yielding an
Figure 3. Division of S-warfarin (left) and dextromethorphan (right)
into QM (black) and MM (red) regions, as applied in QM/MM
calculations here. The N-protonated form of dextromethorphan, used
in the 2D6 simulations, is shown here.
51
Figure 4. Thermodynamic cycle showing the importance of the FeO
bond energy ΔE2 in the reactivity of Cpd I with the substrate RH.15468 dx.doi.org/10.1021/ja203157u |J. Am. Chem. Soc. 2011, 133, 15464–15474
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unrelaxed Fe(III) species, which was treated as a low-spin (doublet)
state, with energy EQM/MM(Fe*). The energy EQM(O) of the (triplet
state) oxygen atom was also calculated, in vacuo. Next, the relaxation
energy was calculated using asmall model comprising only the porphyr-
inring,iron,and
SHthiolateligand,i.e.,assumingthatthiscontribution
should be eﬀectively equal for each isoform and each environment. We
stress here again that the aim was to develop a quick and undemanding
method to approximately calculate the relative reactivity of Cpd I. The
diﬀerence in energy EQM(Fe)  EQM(Fe*), computed for the doublet
state, was found to be 24.5 kcal mol
1 at the B3LYP/LACVP,6-31G*
level of theory. Note that the true resting state of P450 enzymes usually
involveseithercoordinationofawatermoleculetothehemeiron(III)or
a pentacoordinate iron(III) in the high-spin (sextet) state. Indeed,
B3LYP calculations ﬁnd that the ground state of the pentacoordinate
states is the sextet.
68,69 However, it can be assumed that the change in
energy from one spin state to another, and upon binding water, is
relatively small and approximately constant from one isoform to
another, so can be neglected for the present purposes of examining
the relative value of ΔE2 for diﬀerent isoforms and for diﬀerent heme
groupenvironments.Insummary,ΔE2isobtained,foreachstructure,as
ΔE2 = EQM(O) + EQM(Fe)  EQM(Fe*) + EQM/MM(Fe*)  EQM/MM
(FeO).
To explore the eﬀect of the way in which the substrate is treated in
thesecalculations(i.e.,usingQMorMM)onthecalculatedFeObond
enthalpies, test calculations ofthe typedescribed above werecarried out
in both ways for the 2D6_dex system. In one set of calculations, the
entire dextromethorphan molecule was placed in the MM region,
whereas in the other, it was placed partly in the QM region and partly
in the MM region, as shown in Figure 3. The calculated FeO bond
energies using these two approaches were found to be the same, within
0.2 kcal mol
1, for each structure considered. Hence it is assumed that
the treatment of the substrate does not have an eﬀect on the calculated
electronic structure of Cpd I.
’RESULTS AND DISCUSSION
Electronic Structure of Cpd I in Substrate-Free Systems.
The electronic structure of Cpd I was compared between four
different isoforms in the absence of substrate in the active site.
These systems are the 2C9_apo, 2D6_apo, 3A4_apo, and
P450cam_apo systems described above. Snapshots were taken
from each MD simulation every 200 ps and subsequently
optimized, first with MM and then with the QM/MM method,
as described above. This yielded 26 QM/MM optimized
geometries for each simulation (with the exception of the
2D6_apo simulation in which only 10 optimized geometries
were calculated). The electronic structure of each optimized
structure was inspected to ensure that the correct wave function
for Cpd I had been found.
15
Comparisons of the electronic structure of Cpd I between
systems were made by observation of several quantities in the
QM/MM optimized structures. These include the FeO and
FeS bond lengths and Mulliken charges and spin densities of
atoms in the Cpd I moiety. These are presented in detail in the
Supporting Information. Large deviations in these quantities
would reﬂect large diﬀerences in electronic structure between
snapshots, including the amount of delocalization of the third
unpaired electron between the sulfur p orbital and the porphine
a2u orbital. Table 2 shows the average FeS bond lengths and
Mulliken spin densities for the sulfur, oxygen, iron, and porphyr-
in, calculated for each set of snapshots in the substrate-free
systems as well as the associated standard deviations. No indica-
tionofanyoverallchangeinthecalculatedquantitieswithrespect
to thetime point intheMD runat which theinitialsnapshot was
selected was noticed for any of the above observables (more
detailisgivenintheSupportingInformation).Wenotethatifthe
MD simulation generates an equilibrium ensemble of structures,
thennosuchtimedependencewouldbeexpected,sothelackofa
trend provides an indication that the MD simulations are well
equilibrated for the present purposes. The FeS bond lengths
(and Mulliken spin densities) are close to those observed in
previous work.
15,35 The average value of the FeS bond length
falls within the range of the largest standard deviation obtained
(0.08 Å) for all four isoforms, indicating that there is no
appreciable diﬀerence in structure between these isoforms. The
FeO bond length also shows no signiﬁcant variation between
diﬀerentP450systems; theaverage valueof1.62Åisobservedin
allsystems,withastandarddeviationof0.Theaveragesulfurspin
densitiesshowasmalldegreeofvariation(lessthan0.2),withthe
value found to increase from one isoform to another in propor-
tion to the size of the active site cavity (P450cam < 2D6 < 2C9 <
3A4).However,thistrendisprobablynotsigniﬁcant,becauseitis
of the order of the standard deviations. An increase in sulfur spin
density is accompanied by a decrease in porphyrin spin density,
with the sum of the two quantities remaining close to 1. All
average iron and oxygen spin densities lie within the standard
deviations and hence appear not to vary between isoforms.
Electronic Structure of Cpd I in the Substrate-Bound
Systems. In previous work,
14 it was observed that the absence
of substrate in the active site of CYP3A4 leads to elongation of
the FeS bond and localization of the radical on sulfur. In this
work, the FeS bond lengths and Mulliken spin densities on the
ferryl oxygen and cysteinate sulfur atoms were calculated for the
Table 2. Average FeS bond length (Å) and Mulliken Spin Densities (G) of Sulfur and Oxygen (with standard deviations, σ) for
the QM/MM Optimized Snapshots of Cpd I
FeS σ FeO σ F(Fe) σ F(S) σ F(O) σ F(porph) σ
2C9_apo 2.67 0.08 1.62 0.0 1.17 0.03 0.43 0.07 0.77 0.03 0.63 0.06
2D6_apo 2.69 0.05 1.62 0.0 1.15 0.03 0.41 0.04 0.76 0.02 0.62 0.03
3A4_apo 2.60 0.04 1.62 0.0 1.16 0.02 0.47 0.05 0.78 0.03 0.56 0.05
P450cam_apo 2.63 0.06 1.62 0.0 1.15 0.04 0.34 0.05 0.80 0.04 0.70 0.05
2C9_prox 2.61 0.03 1.62 0.0 1.18 0.03 0.46 0.06 0.76 0.03 0.56 0.06
2C9_2warf 2.62 0.06 1.62 0.0 1.14 0.02 0.40 0.04 0.81 0.02 0.62 0.05
2C9_dist 2.60 0.04 1.62 0.0 1.16 0.02 0.45 0.06 0.78 0.03 0.57 0.05
2D6_dex 2.59 0.03 1.62 0.0 1.14 0.02 0.37 0.04 0.81 0.02 0.66 0.04
3A4_dex 2.58 0.03 1.62 0.0 1.15 0.03 0.44 0.06 0.79 0.03 0.59 0.06
P450cam_prop 2.60 0.02 1.62 0.0 1.14 0.02 0.27 0.05 0.81 0.02 0.76 0.0615469 dx.doi.org/10.1021/ja203157u |J. Am. Chem. Soc. 2011, 133, 15464–15474
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substrate-bound systems, 2C9_dist, 2C9_prox, 2C9_2warf,
2d6_dex, 3A4_dex, and P450cam_prop. The average values
and standard deviations for these quantities are presented in
Table 2.
Foralloftheisoformsstudied,thereisaslightreductioninthe
average FeS bond length, compared with the corresponding
substrate-free systems. However, this reduction is small com-
pared to the standard deviation, σ. Similarly, the average spin
densityonsulfurisslightlyreducedinthesubstrate-boundforms,
although not in the case of 2C9. This is in agreement with
previous work,
14 but it is diﬃcult to draw any conclusions based
on this observation alone. As with the substrate-free systems,
thereisnotimedependence observedinanybondlengthorspin
density(Supporting Information).Thisisincontrast toprevious
work,
14 where a time dependence was noted, but based on
calculations performed on signiﬁcantly fewer structures. This
again stresses the need to sample many conformations of the
protein in order to draw reliable conclusions from QM/MM
calculations. The variation in the QM/MM optimized structures
of Cpd I, and the residues surrounding the cysteinate sulfur, for
the 2C9_dist simulation are illustrated in Figure 5. Figure 5
shows a comparable (if not larger) variation in protein structure
surroundingthecysteinateligandbetweenstructuresofthesame
isoform, than between diﬀerent isoforms (Figure 1). The root-
mean-square deviation (rmsd) of the positions of the Cpd I,
Cys435,Leu358,Gly359,andGln360atomscomparedtothet=
0 ps snapshot are shown in Figure 6. From Figure 6 it can be
noted that none of the snapshots vary by more than 0.7 Å
compared to the initial QM/MM optimized structures and that
thereisnotimedependenceinthevariationinthesecoordinates.
Figures 5 and 6 provide evidence to suggest that the MD
simulations are well-equilibrated and that an adequate ensemble
of geometries has been studied.
The calculations predict a diﬀerence between the electronic
structure of Cpd I in the bacterial P450cam and human P450
isoforms, as indicated by the smaller spin density on sulfur in the
bacterial isoform, both in substrate-bound and -free forms.
Furthermore, this diﬀerence cannot be explained by the ﬂuctua-
tion observed in other properties, as reﬂected by the standard
deviations.Thespindensityonsulfurislinkeddirectlytothespin
density on the porphyrin ring (see, e.g., the frontier orbital a2u in
Figure 1) and could inﬂuence the reactivity of Cpd I.
3,9,10
This diﬀerence between the bacterial and human isoforms is in
agreement with our previous ﬁndings
15 and has been explained
by the slightly diﬀerent hydrogen-bonding environment sur-
rounding the sulfur atom. As shown in Table 1, in all of the
isoforms studied, the residue Resn+2 (where Resn corresponds to
the cysteinate that is coordinated to the Fe) is a conserved
glycine, which is common to all P450 isoforms.
70 The amide
protonof this glycine forms a hydrogen bondwiththe cysteinate
sulfurinalloftheisoformsstudied(seeFigure7).IntheP450cam
calculations, this hydrogen bond is found to be stronger, and
shorter(byaround0.1Å)thaninthehumanisoforms.Hydrogen
bonding is believed to alter the energy of the sulfur p orbital,
relativetotheporphyrina2u,leadingtoareductionintheamount
of mixing between the two orbitals.
20
An interesting observation noted for the 2C9_prox and
P450cam_prop MD simulations is that the conformation of the
protein backbone for the conserved glycine located two amino
acids along from the coordinating cysteine (Resn+2) ﬂipped
during the simulation. This resulted in the loss of the hydro-
gen-bondinginteractionbetweentheamideprotonoftheglycine
and the cysteinate sulfur atom (shown for P450cam in Figure 7).
For many snapshots, the absence of this hydrogen bond corre-
sponds to an increase in spin density on the sulfur and to
elongation (and, in some cases, breakage) of the FeS bond
during the QM/MM optimization. While the change in con-
formation of the glycine is believed to be an artifact of the
simulations, it highlights the importance of the hydrogen-bond-
ing interaction between the amide proton of the glycine and the
cysteine in the stabilization of Cpd I.
The spin density on the ferryl oxygen is linked directly to the
spin density on iron. The observed standard deviation of these
quantities (0.020.04) is smaller than that of the sulfur spin
density (0.040.07), indicating a smaller sensitivity to the
ﬂuctuations of the surroundings in the former. It is possible that
the presence of substrate may have a small eﬀect on the ferryl
oxygen spin density, as shown by the data for the 2D6, 3A4, and
P450camisoformsinTable2.Theamountofspindensityislarger
by approximately 0.01 in the models where substrate is present,
comparedtotheapoenzymes.Thisdiﬀerenceissmaller thanthe
standarddeviation,sosomecautionisneededbeforeinterpreting
Figure 6. Root mean square deviation (rmsd) of the coordinates of the
Cpd I, Cys435, Leu358, Gly359 and Gln360 residues, in the optimized
QM/MM structures from the 2C9_dist simulation (relative to the
t = 0 ps optimized geometry).
Figure 5. Overlay of QM/MM minimized structures from the
2C9_dist simulation. For clarity, only the Cpd I, Cys435, Leu358,
Gly359, and Gln360 residues are shown.15470 dx.doi.org/10.1021/ja203157u |J. Am. Chem. Soc. 2011, 133, 15464–15474
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it as meaningful. As discussed below, though, this quantity is
foundtocorrelatewiththecalculatedbondenergies,soitmaybe
a genuine diﬀerence between the ligand-bound and -free forms.
Stability of Cpd I. We now consider the approximate FeO
bond energies ΔE2. Table 3 displays the average values of ΔE2
calculated from QM/MM minimized structures taken from the
2C9_apo, 2C9_dist, 2C9_2warf, 2C9_prox, P450cam_prop,
2D6_apo, 2D6_dex, 3A4_apo, and 3A4_dex simulations
(detailed information is in the Supporting Information). The
majorityofthe FeObond energies fall within therange 4962
kcal mol
1. The energy ΔE3 for adding an oxygen atom into a
CH bond of methane or other simple substrates, such as
propene, is of the order of 90 kcal mol
1.
72 Combined with
theapproximatevalueofΔE2of50kcalmol
1inthepresenceof
substrate, this suggests that the overall reaction energy for CH
bond oxidation by Cpd I should be of the order of 40 kcal
mol
1, a value which agrees very well with typical calculated
reaction energies.
20 This suggests that despite its approximate
nature, the definition of the bond energy ΔE2 used here is
physically reasonable.
There is considerable ﬂuctuation in the values obtained over
the course of all the simulations. The most extreme example of
this case is the 2C9_prox case, where the FeO bond enthalpy
varies between 46.2 and 76.8 kcal mol
1. The largest values are
those where the FeS bond is broken (i.e., >3.0 Å), as discussed
aboveandthereforearenotincludedinthecalculationofaverage
values.
The values of the average ΔE2 for diﬀerent systems all fall
within the range of values obtained for any particular simulation,
suggesting that there is no major diﬀerence in bond energy from
one isoform to another, which is expected given the fairly
constant chemical environment in each case. However, one
possibly signiﬁcant trend is that in the presence of a substrate
molecule in the active site, the average value of ΔE2 is slightly
lower than in its absence. For example, of the CYP2C9 models,
theaverageFeObondenthalpyfollowstheorder2C9_2warf<
2C9_dist≈2C9_prox<2C9_apo.Thistrendismirroredinthe
P450cam and CYP2D6 simulations, where the presence of sub-
strate signiﬁcantly lowers the average FeO bond enthalpy.
The weakening eﬀect of the substrate molecule on the FeO
bondcanbedescribedintermsofseveralmostlycomplementary
eﬀects: (a) One is that the presence of the substrate could
directlyaﬀectthepolarizationoftheFeObond,thusraisingthe
energy of Cpd I relative to the ground state, so that less energy
would be required for its breakage. The energy of formation of
Cpd I from Cpd 0 has been calculated by Zheng et al.
73 to be
around4kcalmol
1,hencethedestabilizationeﬀectcannotbe
very large otherwise Cpd I formation would be unfavorable.
AsimilarestimateoftheenergyofformationofCpdIfromCpd0
is obtained from an analysis of experimental data based on a
thermodynamic cycle.
74 (b) Another possible explanation is that
the presence of substrate stabilizes the resting state of the
enzyme, lowering the energy required to break the FeO bond.
(c) Linked to these two explanations, it is possible that the
substratehasanindirecteﬀectonthestabilityofeithertheresting
state or Cpd I, by changing the preferred conformations of the
surrounding protein and the water in the active site. This could
aﬀect the hydrogen-bonding interactions between the protein
and Cpd I, which have been shown to have an eﬀect on its
electronic structure,
3,4,10,20 as discussed in the Introduction. The
possible eﬀect (a) of substrate polarization of the FeO bond is
exploredinthenextsection.Themostconvincingexplanationof
the eﬀect, in our view, is of type (c) and can be best expressed as
saying that it is not the presence of the substrate that has a large
eﬀect but rather its absence. When no substrate molecule is
bound, more water is able to enter the active site cavity. As a
result, there are more hydrogen-bonding interactions between
the Cpd I ferryl oxygen and the surrounding water molecules in
the absence of substrate.
The average number of hydrogen bonds to the Cpd I ferryl
oxygen, NHB(FeO), throughout all of the MD simulations was
calculated in CHARMM, and these data are shown in Table 3.
AhydrogenbondisdeﬁnedaspresentbetweentheatomsAHD
if the distance between the donor (D) and acceptor (A) is less
than2.8ÅandiftheAHDangleisgreaterthan90.
75NHand
OH groups only were deﬁned as potential hydrogen-bond
donors. As expected, the presence of substrate in the active site
displaces water and hence results in fewer hydrogen bonds, on
average, to the ferryl oxygen. This eﬀect is most apparent in the
2C9 systems: in the 2C9_apo and 2C9_dist simulations in which
there is no substrate molecule close to Cpd I, NHB(FeO) is 1.05
and 1.06, respectively. In the 2C9_prox and 2C9_2warf simula-
tions,where asubstrate moleculeispresentdirectlyabove CpdI,
NHB(FeO) is signiﬁcantly lower (0.50 and 0.14 respectively).
Table 3. Average FeO Bond Enthalpies, ΔE2 [kcal mol
1],
and Standard Deviation, σ, Calculated for QM/MM
Optimized Snapshots
ΔE2 σ
2C9_apo 58.5 3.9
2C9_prox 56.1 2.3
2C9_2warf 49.9 2.3
2C9_dist 55.1 3.8
2D6_apo 61.5 3.5
2D6_dex 49.3 2.5
3A4_apo 55.0 3.3
3A4_dex 54.9 2.7
P450cam_apo 54.9 4.1
P450cam_prop 52.1 1.6
Figure 7. QM/MM optimized structural snapshot of Cpd I and
residues surrounding the cysteinyl sulfur taken from the P450cam_prop
simulation. The hydrogen bond between the amide proton of Gly359
and the sulfur of Cys357 is shown as a red dashed line. This hydrogen-
bonding interaction is present in all of the isoforms studied in this work,
however, the interaction is strongest in the P450cam isoform.15471 dx.doi.org/10.1021/ja203157u |J. Am. Chem. Soc. 2011, 133, 15464–15474
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Hydrogen bonding to neighboring water molecules will lower
the amount of unpaired spin density on the Cpd I oxygen and
hencestabilize CpdI. In this interpretation, CpdI is predictedto
be slightly more oxidizing in the presence of substrate than in its
absence, and this might help to account for its experimental
elusiveness. The presence of substrate has a smaller eﬀect on the
hydrogen bonding between water and the Cpd I oxygen in the
P450camsimulations.Thisisprobablybecausepropeneissmaller
than the other substrates modeled, and therefore, its presence
does notprevent waterfromaccessingCpdI.Wedonotobserve
a hydrogen bond betweenthe hydroxyl groupof Thr309 and the
Cpd I oxygen at any point in the CYP3A4 simulations, contrary
to ﬁndings that were reported previously, based on MM MD
simulations.
14
In the catalytic cycle of CYPs, it is widely accepted that the
substrateisrequiredtobepresentintheactivesiteinordertostart
thechainofstepsleadingtoformationofCpdI.Althoughitmight
be expected that Cpd I will not form in the absence of substrate,
Cpd I in CYP119 has been recently isolated and analyzed spectro-
scopically in the absence of substrate.
16 It has been proposed that
the presence of substrate in the active site of CYPs increases the
stability of Cpd I,
14 which may at ﬁrst seem to contradict our
ﬁndings. However, this claim is made based on the presence of a
substrate preventingCpd I from performinghydrogen abstraction
from active site side chains, such as Ala305 and Thr309 in
CYP3A4.
14 Here we consider how the intrinsic stability of Cpd I
may diﬀer between the substrate-free and -bound systems.
It is to be noted that the protocol used here to estimate the
FeO bond energy ΔE2 is only approximate. In particular,
structural relaxation that occurs after breaking the FeO bond
is treated here only for the heme group itself. The rest of the
system would also undergo various structural changes, and this
relaxation eﬀect is not treated here. Given the larger number of
hydrogen bonds to the ferryl oxygen in the systems without
substrate in the active site, the water present in the active site
would presumably undergo larger amplitude relaxation in the
substrate-free cases. This would correspond to a decrease in the
FeO bond energy, thereby bringing the substrate-bound and -
free values closer together. Nevertheless, the results obtained
here do suggest that the ferryl bond in P450 Cpd I is intrinsically
somewhat more reactive when it is in a more hydrophobic
environment, as when substrate is present. It has been suggested
previously that hydrogen bonding to Cpd I by a water molecule
can lower the barrier to hydrogen abstraction in some cases.
76,77
Thiseﬀectwasrationalizedbysuggestingthatthehydrogenbond
increased in strength from the reactant complex to the transition
state, as a greater negative charge is observed on the oxo atom in
the transition state than the reactant complex. In this study, we
do notconsider transitionstates,sowe cannotcommentdirectly
on whether this eﬀect would be generally observed. We note,
however, that the eﬀect is quite small when using large basis
sets,
77 and our calculations suggest that there is very little water
present in the reactant complexes in the presence of bulky
substrates. Two comments are needed here: First, previous
studies
36,37 have suggested that the key factor aﬀecting reactivity
inCHbondabstractionbyametaloxospeciessuch,asCpdI,is
the strength of the resulting OH bond. We have argued above
that for Cpd I in a range of diﬀerent environments, a stronger
FeO bond is likely to be correlated with a weaker OH bond,
thustheFeObondenergyprovidessomeinformationonlikely
reactivity. Asthis anticorrelationwillnotbeperfect, thiswillonly
providearoughguideline.Second,ourcalculationsincludesome
cases where Cpd I has no close-lying water molecule. At ﬁrst
sight, this is inconsistent with the fact that Cpd I formation from
theCpd0precursorleadstoformationofonemoleculeofwater.
However, between formation and reaction of Cpd I, the water
molecule can diﬀuse awayifitis favorable infree energy terms to
doso.Variouspreviousstudieshaveshownthatwaterdiﬀusionis
fairly rapid on the millisecond time scale for Cpd I turnover.
78
Our discussion here assumes that the ensemble of structures
generated by the MD simulations is a realistic representation of
CpdIandthatwheretheMDsimulationsuggeststhatnowateris
present, this represents the preferred environment.
Influence of the Ferryl Oxygen Spin Density on the FeO
Bond Energy.The FeO bond energy is influenced by the spin
polarizationoftheFeObond,whichisaffectedbythepresence
or absence of substrate. As mentioned above, the absence of a
substrate molecule in the active site generally results in an
increase in water molecules surrounding the ferryl oxygen. The
increase in hydrogen-bonding interactions between the Cpd I
ferryl oxygen and surrounding water molecules leads to a
decrease in the spin polarization of the FeO bond, for the
reasons discussed below. Therefore, in the substrate-free calcula-
tions, the ferryl oxygen spin density will be, in general, slightly
lower than in the calculations where substrate is present. In
Figure 8, the FeO bond enthalpies are plotted against the spin
Figure 8. FeO bondenthalpy, E(FeO) [kcal mol
1] plotted versus
Cpd I ferryl oxygen spin density (F(O)) for multiple structures for
diﬀerent CYP isoforms (indicated by diﬀerent symbols and colors, as
shown in the legend).
Table 4. Average Number of Hydrogen Bonds (NHB(FeO))
Formed between the Ferryl Oxygen and Active Site Water
Molecules during Each of the 5 ns MD Simulations
NHB(FeO)
2C9_apo 1.05
2C9_prox 0.50
2C9_2warf 0.14
2C9_dist 1.06
2D6_apo 0.92
2D6_dex 0
3A4_apo 1.04
3A4_dex 1.15
P450cam_apo 1.16
P450cam_prop 0.9715472 dx.doi.org/10.1021/ja203157u |J. Am. Chem. Soc. 2011, 133, 15464–15474
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densities on the ferryl oxygen atom for the QM/MM optimized
geometries of CpdI. Figure 8shows adirectcorrelation between
the ferryl oxygen spin density and the FeO bond enthalpy
calculated for a particular structural snapshot. The QM/MM
optimized structures with the highest spin densities on oxygen
(i.e., with the largest amount of FeO spin polarization) tend to
have the lowest FeO bond enthalpies. The simulations where
the substrate is in a position in which it can react with Cpd I, for
example 2C9_2warf and P450cam_prop, have larger spin den-
sities on the ferryl oxygen and also lower FeO bond enthalpies
than those with a distal substrate or no substrate, e.g., 2C9_dist
and 2C9_apo, for the reasons mentioned above (see Table 4).
The formation of Cpd I is usually preceded in the catalytic
cyclebyentranceofthesubstrateintotheactivesitecavity,asthe
substrate is believed to displace the water molecule thatis bound
to the Fe(III) resting state. The displacement of this water
molecule results in a spin-state change for the Fe(III), which
facilitates the ﬁrst electron transfer which precedes the subse-
quent steps to Cpd I formation. It therefore seems reasonable to
imagine that the reactivity of Cpd I might somehow be aﬀected
by the presence of substrate. It would appear from Figure 4 that
the diﬀerence inreactivityof Cpd Ibetween the substrate-bound
and -free forms is, at least in part, due to the substrate increasing
the amount of unpaired electron density on the ferryl oxygen.
Thisincreaseinspindensityismostlikelyduetodisplacementof
theactivesitewatermoleculesbythesubstrate,resultinginfewer
hydrogen-bonding interactions with the Cpd I oxygen. Ir-
onoxygen bonding involves two two-center three-electron π
bonds,withtheunpairedelectronsresidinginπ*orbitalsthatare
shared between the oxygen px (or py) and metal dxz (or dyz)
orbitals. Hydrogen bonds to oxygen lower the energy of its p
orbitals, thereby increasing the O character of the bonding π
orbitals, decreasing the O character of the π* orbitals, and
lowering the spin density on O. By displacing water from the
active site, the substrate reverses this eﬀect, so that there is more
spin density on oxygen. This also has the eﬀect of slightly
increasing the FeO bond length, and presumably, decreasing
its bond energy. Mn(V)dO complexes have been found to be
more reactive when more spin is located on the oxo atom.
79,80
HencetheoxidizingcapabilityofCpdIisenhanced,comparedto
theapoenzyme,inthepresenceofsubstrate.Thiseﬀectmayvary
dependingonthesizeofthesubstrateandtheactivesitecavity,as
thesebothinﬂuencethenumberofwatermoleculesabletoenter
the active site. This is evident from Table 4 where in the case of
model systems in which the active site and the substrate have
similar sizes (e.g., 2D6_apo and 2C9_prox), fewer hydrogen-
bondinginteractionsareobservedbetweenwaterandtheCpd
I ferryloxygen.Notealsothatwedonotclaimthiseﬀectto be
catalytic; clearly it is not sensible to discuss the possibility of
catalysisintheabsenceofsubstrate.Analyzingcatalysiswould
require comparison of the reaction in diﬀerent environments.
Our results do indicate, however, that Cpd I has somewhat
diﬀerentpropertiesdependingonwhethersubstrateispresent
or not, due to its interaction with water molecules (or lack
thereof). This may have important implications for under-
standing its stability, formation, and/or reactivity in the
absence of substrate.
’CONCLUSIONS
The electronic structure of Cpd I displays little variation
between the three human isoforms studied: 2C9, 3A4, and
2D6. There is more signiﬁcant variation for any single isoform
(i.e., between diﬀerent conformations generated by MD) than
between isoforms. This indicates that Cpd I is sensitive to
changes in the polarization and hydrogen-bonding environment
(this is what Shaik et al. have referred to as the “chameleon”
eﬀect).
3,10 The bacterial CYP isoform P450cam shows a signiﬁ-
cantly sulfur spin density compared to the human isoforms. On
average, the hydrogen-bonding environment is similar in all of
the human isoforms studied here.
The presence of substrate in the active sites of the human and
bacterialisoformshasaneﬀectontheelectronicstructureofCpd
I. The presence of substrate results in a slight shortening of the
FeS bond and a decrease in the amount of spin density on the
cysteinate sulfur. This is likely to be due to the displacement of
water molecules from the active site by the substrate.
An approximate method for estimating the FeO bond
enthalpy of Cpd I is presented here and used to investigate the
variation of the oxidizing ability of diﬀerent CYP isoforms.
Diﬀerences in the FeO bond enthalpy between isoforms are
within the variation observed between diﬀerent structures of the
same isoform. This suggests that there is not a signiﬁcant
diﬀerence in oxidizing power between diﬀerent isoforms. The
presence of substrate in the active site cavity slightly lowers the
energy required to break the FeO bond. This suggests that the
substrate has a small eﬀect on the electronic structure of Cpd I.
This eﬀect is due to the substrate restricting the number of water
molecules that are able to hydrogen bond to the ferryl Cpd I
oxygen. When substrate is bound, fewer hydrogen bonds are
donated by water molecules to the ferryl oxygen. Without
these solvent hydrogen bonds, the spin density on the oxygen
increases, while the charge associated with it decreases. The
FeObondenergyshowsanapproximatelylinearcorrelation
withthespindensityontheoxygenatom.QM/MMoptimized
structures with the largest amount of spin density on the
f e r r y lo x y g e no fC p dIt e n dt oh a v et h el o w e s tF e Ob o n d
enthalpies.
From this work it appears that Cpd I has a very similar
electronic structure in diﬀerent isoforms, especially between
the human isoforms studied here. It hence seems reasonable to
assume Cpd I will show similar reactivity across diﬀerent CYP
isoforms.
The QM/MM calculations also show that the electronic
structure of Cpd I varies due to thermal ﬂuctuations, which lead
to motion of protein residues, substrate, and water molecules,
and hence to changes in the hydrogen-bonding environment
surrounding the heme group and especially the cysteinate sulfur.
Theeﬀectoftheﬂuctuationofthesurroundingenvironmentmay
mean that conclusions about electronicstructure based on single
QM/MMoptimizedstructuresarenotrobust,andpropertiesare
better derived from averaging over a number of diﬀerent con-
formers,ashasalsobeenfoundforcalculatingenergybarriersfor
oxidation of alkenes in P450s.
35
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